We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Data released by Brazilian drug industry federation Febrafarma indicates that local drug consumption declined in the first half of 2005, but market value has continued to soar in US dollar terms.
Amid plans to streamline its healthcare regulation, India could create a new agency to monitor clinical trials, with standards modelled along US FDA lines.
DSM, the world-leading supplier of life science and nutritional products, performance materials and industrial chemicals, today opened its first Research and Development (R&D) Center in China. The center is located in Shanghai.
Today at its annual meeting of shareholders, Intrac, Inc. (OTC BB: ITRD) changed its name to Javelin Pharmaceuticals, Inc. as part of a reincorporation in the State of Delaware.
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30) today announced that ProPharma Limited, its formulation subsidiary based in Glasgow, Scotland, will do business under the Evotec brand from the 1st of September 2005.
A $30 million oncology project of Dabur and a $10 million initiative from Nestor Pharma are among two initiatives in the pharmaceuticals sector announced during British Prime Minister Tony Blair's three-day visit here since Tuesday.
Wyeth Pharmaceuticals today formally opened its new billion biotechnology production facility at Grange Castle in Co Dublin, which will employ over 1,000 people.
Shire Pharmaceuticals Group PLC is proposing to introduce a new UK-listed holding company and reduce the new company's share capital to create distributable reserves, a move which Shire says will aid the payment of dividends.